Pulse Biosciences (PLSE) Long-Term Debt Issuances (2021 - 2023)

Pulse Biosciences has reported Long-Term Debt Issuances for 3 years, with the latest figure at -$1.7 million in Q3 2023.

• On a quarterly basis, Long-Term Debt Issuances fell 102.7% year-over-year to -$1.7 million in Q3 2023; TTM through Jun 2024 was -$1.7 million, a 102.63% decrease from a year earlier, with the FY2022 full-year figure at $65.0 million, up 3252.24% from the prior year.
• Long-Term Debt Issuances was -$1.7 million for Q3 2023 at Pulse Biosciences, down from $828000.0 in the prior quarter.
• The five-year high for Long-Term Debt Issuances was $64.6 million in Q3 2022, with the low at -$39.3 million in Q2 2021.
• Average Long-Term Debt Issuances over 3 years is $8.4 million, with a median of $632500.0 recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Long-Term Debt Issuances jumped 30791.39% in 2022, then slumped 102.7% in 2023.
• Over 3 years, Long-Term Debt Issuances stood at $209000.0 in 2021, then surged by 30791.39% to $64.6 million in 2022, then slumped by 102.7% to -$1.7 million in 2023.
• The last three Long-Term Debt Issuances figures came in at -$1.7 million (Q3 2023), $828000.0 (Q2 2023), and $917000.0 (Q1 2023), per Business Quant data.